Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Atishoo! From babies with colds to bird flu - new centre to tackle respiratory infections

02.06.2008
Think that colds and flu are easy to catch, hard to avoid and impossible to treat? That nobody ever dies of a cold? That's all wrong, say the medics and scientists at a new research centre which launches today (Monday 2 June).

Research into respiratory infections is an urgent priority, they argue. Colds can be a very serious problem for the elderly, babies, and patients with lung disease. History suggests a major flu pandemic is overdue and drug resistant tuberculosis and other 'superbugs' are on the rise.

The new Centre for Respiratory Infection at Imperial College London aims to tackle these issues. It is funded by a £3.4 million award from the Wellcome Trust and will bring together more than 200 scientists to work on a range of problems - how common cold viruses cause disease and affect long-term health, how to make better vaccines to prevent lung infections, and how to diagnose TB more accurately. The centre will also be ready to spring into action if there is a new outbreak of pandemic flu such as a mutated form of bird flu, or SARS.

Professor Peter Openshaw, the Director of the new centre from the National Heart and Lung Institute at Imperial College London, said: "Respiratory disease has never been as well funded as it deserves to be, considering the impact it has on health. Respiratory infections are at the root of many of the diseases that we treat every day. This new initiative is a great opportunity to get something done. We have a lot of very talented groups working on different aspects of lung infections, and bringing them together with solid shared support will help them work on common goals, to the great benefit of patients".

Examples of problems which the centre will tackle include:

* How to quickly bring a flu pandemic under control

Researchers from the new centre are establishing a clinical team that will bring doctors and researchers together to bring a future flu pandemic under control quickly and effectively.

If an outbreak of pandemic flu strikes, doctors will only be able to get the best treatments to patients if they can first analyse the flu strain and find out which therapies are going to work. However, planning and setting up the necessary trials to obtain this information would usually take months.

The new centre will put plans in place in advance, so that researchers can get to work before the epidemic spreads too widely and so that doctors working on the ground are fully prepared.

The researchers will be working closely with colleagues at Imperial College Healthcare NHS Trust and the MRC Centre for Outbreak Analysis and Modelling at Imperial College London, and with other scientists and government agencies across the world.

Professor Openshaw explained: "We can only move fast to bring an epidemic under control if we have staff ready and plans already in place. To plan at the stage when patients start coming in through casualty will be impossible."

* Why the common cold in babies can cause long term health problems

The respiratory syncytial virus (RSV), which causes colds in adults, is the main single cause of hospitalisation in babies under a year of age. It causes most cases of viral bronchiolitis, an infection of the small airways of the lung which leads to breathing problems and which results about 1 in every 40 babies affected being admitted to hospital. Around 40 percent of infants who experience bronchiolitis as a result of RSV infection are affected by recurring wheeze and asthma in childhood.

The researchers will investigate why some babies get severe disease, while the majority recover with ease. Imperial College researchers have already made many important discoveries about RSV, including a study in 2004 which revealed that RSV can 'hit and hide', surviving in the body for many months or years. They are now investigating whether recurrent wheezing in children could be caused by the virus hiding in the lung.

Laura Gallagher | alfa
Further information:
http://www.wellcome.ac.uk
http://www.imperial.ac.uk

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>